These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17017895)

  • 21. Modulation of nitric oxide-dependent relaxation of pig tracheal smooth muscle by inhibitors of guanylyl cyclase and calcium activated potassium channels.
    Kannan MS; Johnson DE
    Life Sci; 1995; 56(25):2229-38. PubMed ID: 7540707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations.
    Schneider F; Lutun P; Hasselmann M; Stoclet JC; Tempé JD
    Intensive Care Med; 1992; 18(5):309-11. PubMed ID: 1527264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model.
    Fernandes D; Sordi R; Pacheco LK; Nardi GM; Heckert BT; Villela CG; Lobo AR; Barja-Fidalgo C; Assreuy J
    J Pharmacol Exp Ther; 2009 Mar; 328(3):991-9. PubMed ID: 19073910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbon monoxide-induced relaxation of the ductus arteriosus in the lamb: evidence against the prime role of guanylyl cyclase.
    Coceani F; Kelsey L; Seidlitz E
    Br J Pharmacol; 1996 Aug; 118(7):1689-96. PubMed ID: 8842433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylene blue: an effective treatment for contrast medium-induced anaphylaxis.
    Oliveira Neto AM; Duarte NM; Vicente WV; Viaro F; Evora PR
    Med Sci Monit; 2003 Nov; 9(11):CS102-6. PubMed ID: 14586280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylene blue for distributive shock: a potential new use of an old antidote.
    Jang DH; Nelson LS; Hoffman RS
    J Med Toxicol; 2013 Sep; 9(3):242-9. PubMed ID: 23580172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
    Fedele E; Jin Y; Varnier G; Raiteri M
    Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylene blue and vasoplegia: who, when, and how?
    Stawicki SP; Sims C; Sarani B; Grossman MD; Gracias VH
    Mini Rev Med Chem; 2008 May; 8(5):472-90. PubMed ID: 18473936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.
    Evora PR; Ribeiro PJ; Vicente WV; Reis CL; Rodrigues AJ; Menardi AC; Alves Junior L; Evora PM; Bassetto S
    Rev Bras Cir Cardiovasc; 2009; 24(3):279-88. PubMed ID: 20011872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.
    Sobey CG; Faraci FM
    Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass.
    Faber P; Ronald A; Millar BW
    Anaesthesia; 2005 Jun; 60(6):575-87. PubMed ID: 15918829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of nitric oxide synthesis by methylene blue.
    Mayer B; Brunner F; Schmidt K
    Biochem Pharmacol; 1993 Jan; 45(2):367-74. PubMed ID: 7679577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock.
    Park BK; Shim TS; Lim CM; Lee SD; Kim WS; Kim DS; Kim WD; Koh Y
    Korean J Intern Med; 2005 Jun; 20(2):123-8. PubMed ID: 16134766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock.
    Zhang H; Rogiers P; Preiser JC; Spapen H; Manikis P; Metz G; Vincent JL
    Crit Care Med; 1995 Oct; 23(10):1711-21. PubMed ID: 7587237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraoperative vasoplegia: methylene blue to the rescue!
    McCartney SL; Duce L; Ghadimi K
    Curr Opin Anaesthesiol; 2018 Feb; 31(1):43-49. PubMed ID: 29176374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
    Hwang TL; Wu CC; Teng CM
    Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylene blue for refractory hypotension: a case report.
    Weissgerber AJ
    AANA J; 2008 Aug; 76(4):271-4. PubMed ID: 18777811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylene blue adjuvant therapy of schizophrenia.
    Deutsch SI; Rosse RB; Schwartz BL; Fay-McCarthy M; Rosenberg PB; Fearing K
    Clin Neuropharmacol; 1997 Aug; 20(4):357-63. PubMed ID: 9260734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock.
    Zingarelli B; Haskó G; Salzman AL; Szabó C
    Crit Care Med; 1999 Sep; 27(9):1701-7. PubMed ID: 10507586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.